Initial Public Offering of 11,676,470 equity shares of face value of (₹) 2 each ("equity shares") of Rossari Biotech Limited (the "company" or the "issuer") for cash at a price of (₹) 425 per equity share (including a share premium of (₹) 423 per equity share) (the "offer price") aggregating to (₹) 496.25 Crores comprising a fresh issue of 1,176,470 equity shares aggregating to (₹) 50* Crores (the "fresh issue") and an offer for sale of 10,500,000 equity shares (the "offered shares") aggregating to (₹) 44.63 Crores, comprising an offer for sale of 5,250,000 equity shares aggregating to (₹) 22.31 Crores by Mr. Edward Menezes and 5,250,000 equity shares aggregating to (₹) 22.31 Crores by Mr. Sunil Chari (the "promoter selling shareholders" or the "selling shareholders"), (the "offer for sale", and together with the fresh issue, the "offer"). The offer shall constitute 22.49% of the post-offer paid up equity share capital of the company. The company has, in consultation with the book running lead managers ("brlms"), undertaken a private placement of equity shares aggregating to (₹) 99.999 Crores ("pre-ipo placement"). The size of the fresh issue of up to (₹) 150 Crores has been reduced by (₹) 99.999 Crores pursuant to the pre-ipo placement and accordingly, the size of the fresh issue is up to (₹) 50. Crores

Minimum Application for shares in Nos : 35     Further Multiples of : 35